Progenity Inc Stock
Progenity Inc Stock price
Key metrics
| Market capitalization | $9.38m |
| Enterprise Value | $44.77m |
| P/E (TTM) P/E ratio | negative |
| EV/Sales (TTM) EV/Sales | 50.30 |
| P/S ratio (TTM) P/S ratio | 10.54 |
| P/B ratio (TTM) P/B ratio | negative |
| Revenue growth (TTM) Revenue growth | 4,855.56% |
| Revenue (TTM) Revenue | $890.00k |
| EBIT (operating result TTM) EBIT | $-60.87m |
Is Progenity Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
Progenity Inc Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast Progenity Inc:
Analyst Opinions
1 Analyst has issued a forecast Progenity Inc:
Financial data from Progenity Inc
| Sep '24 |
+/-
%
|
||
| Revenue | 0.89 0.89 |
4,350%
4,350%
|
|
| Gross Profit | 0.89 0.89 |
253%
253%
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -61 -61 |
10%
10%
|
| Net Profit | -32 -32 |
74%
74%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Progenity Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Progenity, Inc., a biotechnology company, provides complex molecular and specialized testing services to physicians, clinicians, and their patients in the United States. It offers testing services for common hereditary disorders, cystic fibrosis, spinal muscular atrophy, fragile X syndrome, and Jewish genetic diseases; pan-ethnic carrier screening services; non-invasive prenatal, miscarriage, and pharmacogenetic testing services; and ovarian assessment reports for women. The company also provides pediatric testing services. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November, 2013. The company was incorporated in 2012 and is based in San Diego, California with a laboratory in Ann Arbor, Michigan. It has a bill payment location in Detroit, Michigan.
| Head office | United States |
| CEO | Adi Mohanty |
| Employees | 58 |
| Founded | 2010 |
| Website | www.bioratherapeutics.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
